LeMaitre Vascular ROA 2007-2018 | LMAT

Current and historical return on assets (ROA) values for LeMaitre Vascular (LMAT) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. LeMaitre Vascular ROA for the three months ending September 30, 2018 was 15.38%.
LeMaitre Vascular ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2018-09-30 $0.02B $0.14B 15.67%
2018-06-30 $0.02B $0.14B 17.15%
2018-03-31 $0.02B $0.13B 14.75%
2017-12-31 $0.02B $0.13B 14.59%
2017-09-30 $0.02B $0.12B 14.48%
2017-06-30 $0.01B $0.11B 13.27%
2017-03-31 $0.01B $0.11B 11.82%
2016-12-31 $0.01B $0.10B 11.22%
2016-09-30 $0.01B $0.10B 11.55%
2016-06-30 $0.01B $0.10B 10.90%
2016-03-31 $0.01B $0.09B 10.17%
2015-12-31 $0.01B $0.09B 9.38%
2015-09-30 $0.01B $0.09B 8.46%
2015-06-30 $0.01B $0.08B 7.32%
2015-03-31 $0.01B $0.08B 6.13%
2014-12-31 $0.00B $0.08B 5.08%
2014-09-30 $0.00B $0.08B 3.95%
2014-06-30 $0.00B $0.08B 4.18%
2014-03-31 $0.00B $0.07B 4.44%
2013-12-31 $0.00B $0.07B 6.06%
2013-09-30 $0.00B $0.07B 6.23%
2013-06-30 $0.00B $0.06B 6.37%
2013-03-31 $0.00B $0.06B 6.48%
2012-12-31 $0.00B $0.06B 4.94%
2012-09-30 $0.00B $0.06B 3.33%
2012-06-30 $0.00B $0.06B 3.31%
2012-03-31 $0.00B $0.06B 3.28%
2011-12-31 $0.00B $0.06B 3.25%
2011-09-30 $0.00B $0.06B 6.43%
2011-06-30 $0.01B $0.06B 8.10%
2011-03-31 $0.01B $0.06B 9.88%
2010-12-31 $0.01B $0.06B 11.72%
2010-09-30 $0.01B $0.06B 10.30%
2010-06-30 $0.01B $0.06B 8.77%
2010-03-31 $0.00B $0.06B 7.14%
2009-12-31 $0.00B $0.06B 1.83%
2009-09-30 $0.00B $0.06B 0.00%
2009-06-30 $-0.00B $0.05B -1.88%
2009-03-31 $-0.00B $0.05B -5.58%
2008-12-31 $-0.00B $0.05B -7.24%
2008-09-30 $-0.01B $0.05B -8.77%
2008-06-30 $-0.01B $0.06B -10.39%
2008-03-31 $-0.01B $0.06B -8.66%
2007-12-31 $-0.00B $0.06B -5.22%
2007-09-30 $-0.00B $0.06B -3.54%
2007-06-30 $-0.00B $0.06B -4.73%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.603B $0.106B
LeMaitre Vascular, Inc. is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects the people worldwide. LeMaitre develops, manufactures, and markets disposable and implantable vascular devices to address the needs of vascular surgeons and interventionalists. LeMaitre's diversified product portfolio consists of twelve well-known brand name products used in arteries and veins outside of the heart and are supported by a growing, specialized and highly trained organization of vascular sales professionals. LeMaitre Vascular offers a wide range of innovative products to vascular surgeons and interventionalists for improving procedure efficacy and minimizing patient recovery time.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $132.673B 26.23
Medtronic (MDT) Ireland $124.635B 18.20
Stryker (SYK) United States $69.927B 25.67
Boston Scientific (BSX) United States $55.591B 27.10
Baxter (BAX) United States $39.448B 24.31
Zimmer Biomet Holdings (ZBH) United States $25.289B 16.23
Smith & Nephew SNATS (SNN) United Kingdom $16.755B 0.00
ResMed (RMD) United States $14.297B 27.11
Canopy Growth (CGC) Canada $10.742B 0.00
Bio-Rad Laboratories (BIO) United States $8.172B 52.25
Aurora Cannabis (ACB) Canada $7.060B 50.50
Hill-Rom Holdings (HRC) United States $6.958B 21.52
Perrigo (PRGO) Ireland $6.649B 10.09
ICU Medical (ICUI) United States $5.184B 28.88
Insulet (PODD) United States $5.071B 0.00
Haemonetics (HAE) United States $4.540B 40.28
GW Pharmaceuticals (GWPH) United Kingdom $4.400B 0.00
Agios Pharmaceuticals (AGIO) United States $3.380B 0.00
Hutchison China MediTech (HCM) China $3.329B 0.00
Neogen (NEOG) United States $3.267B 50.18
NuVasive (NUVA) United States $2.850B 24.96
Quidel (QDEL) United States $2.761B 24.91
National Vision Holdings (EYE) United States $2.637B 51.01
Aphria (APHA) $2.539B 112.78
NxStage Medical (NXTM) United States $2.000B 0.00
AtriCure (ATRC) United States $1.274B 0.00
HEXO (HEXO) $1.242B 0.00
Cardiovascular Systems (CSII) United States $1.240B 890.25
Phibro Animal Health (PAHC) United States $1.220B 17.53
VAREX IMAGING (VREX) United States $1.212B 23.73
MacroGenics (MGNX) United States $0.939B 0.00
Cerus (CERS) United States $0.904B 0.00
PetIQ (PETQ) United States $0.867B 22.47
Lantheus Holdings (LNTH) United States $0.847B 22.95
Surmodics (SRDX) United States $0.785B 114.20
Meridian Bioscience (VIVO) United States $0.733B 21.85
NanoString Technologies (NSTG) United States $0.721B 0.00
OraSure Technologies (OSUR) United States $0.720B 31.76
Omeros (OMER) United States $0.719B 0.00
Evolus (EOLS) United States $0.705B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.647B 20.75
Quanterix (QTRX) United States $0.518B 0.00
Insys Therapeutics (INSY) United States $0.426B 0.00
Owens & Minor (OMI) United States $0.408B 5.65
TG Therapeutics (TGTX) United States $0.398B 0.00
Utah Medical Products (UTMD) United States $0.339B 21.99
BioLife Solutions (BLFS) United States $0.329B 445.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.294B 0.00
Vapotherm (VAPO) United States $0.288B 0.00
Bovie Medical (APYX) United States $0.282B 0.00
Rockwell Medical (RMTI) United States $0.262B 0.00
Cytosorbents (CTSO) United States $0.256B 0.00
Zynex (ZYXI) United States $0.174B 16.84
Fonar (FONR) United States $0.144B 7.70
Surface Oncology (SURF) United States $0.140B 0.00
Chembio Diagnostics (CEMI) United States $0.112B 0.00
Chimerix (CMRX) United States $0.100B 0.00
United-Guardian (UG) United States $0.090B 18.77
Female Health (VERU) United States $0.084B 0.00
InfuSystems Holdings (INFU) United States $0.078B 0.00
CAS Medical Systems (CASM) United States $0.070B 0.00
Trinity Biotech (TRIB) Ireland $0.066B 18.20
Conatus Pharmaceuticals (CNAT) United States $0.057B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.056B 0.00
ImmuCell (ICCC) United States $0.038B 0.00
Neurotrope (NTRP) United States $0.034B 0.00
Senestech (SNES) United States $0.021B 0.00
Myomo (MYO) United States $0.016B 0.00
Akers Biosciences Inc (AKER) United States $0.014B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.014B 0.00
Capricor Therapeutics (CAPR) United States $0.013B 0.00
Valeritas Holdings (VLRX) United States $0.010B 0.00
Cellectar Biosciences (CLRB) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.008B 14.14